Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

FDA issues final rule to more closely align with ISO 13485

By Mahnu Davar on February 8, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

On 2 February 2024, the US Food and Drug Administration (FDA) published its much anticipated final rule amending the medical device Quality System Regulation, which sets out the FDA’s quality management system (QMS) requirements for medical devices. The amendments seek to align more closely with International Standard Organization (ISO) standard 13485:2016, Medical Devices — Quality Management System Requirements for Regulatory Purposes. The ISO standard is the version used in much of the world and provides a good framework for meeting the requirements in the EU Medical Devices Regulation (MDR).

The FDA’s decision to align the US QMS requirements to international standards is one of many efforts undertaken by the Agency to promote global regulatory harmonization. Ex-US device and tech developers will hopefully receive some of the efficiency and alignment they were hoping for when it comes to quality system compliance requirements in the US.

You can read more in our advisory.

  • Posted in:
    Health Care and Life Sciences
  • Blog:
    BioSlice Blog
  • Organization:
    Arnold & Porter Kaye Scholer LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo